Related Experiment Videos
Major vessel involvement in Behçet disease
Kenneth T Calamia1, Michael Schirmer, Melike Melikoglu
1Mayo Clinic College of Medicine, Jacksonville, Florida 32225, USA. calamia@mayo.edu
Current Opinion in Rheumatology
|December 18, 2004
Summary
Early recognition and aggressive treatment of large vessel vasculitis in Behçet disease (BD) are crucial. Improved management strategies are reducing morbidity and mortality in these high-risk patients.
Area of Science:
- Rheumatology
- Vascular Medicine
- Immunology
Background:
- Large vessel vasculitis is a serious complication in a subset of Behçet disease patients.
- This condition significantly increases the risk of morbidity and mortality.
- Prompt identification and management are vital for patient outcomes.
Purpose of the Study:
- To review the clinical presentation and management of large vessel issues in Behçet disease.
- To highlight recent advancements in the past year.
- To emphasize the importance of early detection and aggressive treatment.
Main Methods:
- Review of clinical spectrum and management strategies.
- Analysis of recent contributions and clinical experiences.
- Focus on identifying patients at risk for vascular complications.
Main Results:
- Vasculo-Behçet disease patients face risks of thrombosis, stenosis, occlusion, and aneurysms.
- Inflammation of the arterial wall is a primary, though not fully understood, driver of thrombosis.
- Perioperative challenges necessitate collaboration between physicians and surgeons, promoting research into less invasive procedures.
Conclusions:
- Earlier recognition, aggressive medical therapy, and new surgical techniques are improving outcomes for large vessel vasculitis in Behçet disease.
- Clinical experience reports are crucial sources of information due to a lack of controlled studies.
- Continued focus on identifying at-risk patients is a priority for preventing vascular complications.